Director, Pharmacokinetics, Modeling and Simulation Astellas Pharma, Illinois
Join Amit Desai and several authors in Poster Forum #8 in the Solution Center for a conversation about posters on the topic, “From Concept to Clinic: The Power of Modeling and Simulation in Drug Innovation” that he is especially excited about.
W1230-02-12 Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein, Alecia T. Dent, Ph.D., Genentech, Inc.
T1430-02-12 Ocular Pharmacokinetic Model for Intravitreal Antibody Injection, Xianwei Zhang, Ph.D., Boehringer-Ingelheim
M0930-02-09 Predicting Bioequivalence with the COMPASS Tool - Analysis of the Experimental and Literature Data, Dorota Danielak, Ph.D., Physiolution Polska sp. z o. o.
T0930-10-57 Predicting Pharmacokinetic Response of Small Molecules in Rats via Machine Learning, Yorgos M. Psarellis, Ph.D., Sanofi
W0930-10-56 Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader, Radha Ramakrishnan, Ph.D., Bristol-Myers Squibb Company
